M&A & Special Situations

Phase 11 · Elective track · ~16 hours · No hard gate: a C5/C7 booster certified by an ≥85% mastery check

Where it sits. AOL–Time Warner wrote off roughly $99bn of goodwill in 2002. Kraft Heinz took a ~$15.4bn writedown in 2019 on brands it had overpaid for. Deals are where the largest, fastest destructions of shareholder value in history have happened.

This is a Phase 11 elective, one of the optional deepening tracks you take after the core path has already made you a competent analyst, when you want a specialist edge. The core program taught you to value a going concern (Phase 3), judge its earnings (Phase 2), read its management and capital allocation (C7), and compress all of it into a teardown (Phase 8). That machinery now points at the single most consequential thing management ever does with shareholders' money: buy another company, sell a piece of itself, or become the target of someone else's ambition. Deals are where valuation stops being an academic exercise and becomes a negotiated price with a control premium, a financing structure, and a set of promised synergies that the acquirer's own board half-believes. Deals are also where some of the most durable value has been created, quietly, by disciplined serial acquirers and well-timed spin-offs.

The elective's promise is narrow and useful. After it you can build a merger model by hand, tell accretion from value creation (they are not the same thing), read a synergy claim the way a skeptic reads a sell-side note, price a merger-arbitrage spread, and follow an Indian scheme of arrangement from board approval to the record date. The sibling elective E11.01 does the credit-and-covenant version of this same "special situations" toolkit; take both if you want the full event-driven kit.

Suggested hour budget. Core content (read actively, build the little models along): 6h · worked examples: 2h · practice set: 3h · applied mini-project (a full merger model + board memo): 3h · flashcards + mastery check: 2h.

App link. The Deals & Special Situations branch of the skill galaxy grows out of this material: an accretion/dilution drill that regenerates the acquirer/target/financing inputs and grades your pro-forma EPS; a sources-and-uses builder that must balance before it lets you proceed; a merger-arbitrage spread calculator with a break-price stress slider; and a spin-off sum-of-the-parts sandbox. The capstone tier is case CL-11.2: a full merger model you build and defend to a synthetic board.

A note on real deals and synthetic ones. Where this module names a real transaction (HDFC–HDFC Bank, Microsoft–Activision, the Sony–Zee collapse, GE's three-way split), it states as fact only what the public record established: announcement terms, exchange ratios, regulator actions, completions, and disclosed writedowns. Figures are rounded to teaching scale. Every computed example uses synthetic companies, marked "(synthetic)," so that you drill the mechanics on numbers chosen to teach, then re-run them on a live deal as the exercise. The discipline you carry from Phase 2 applies here too: an accretion number is a fact about arithmetic, never a verdict about value.

Learning objectives

By the end you can:

1. Classify any deal along the four axes that determine how you model it: strategic vs financial buyer, cash vs stock vs mixed consideration, asset vs stock (share) purchase, and friendly/negotiated vs hostile/tender. Explain how each axis changes the accounting, the tax, and the risk.
2. Build a sources-and-uses table from scratch, translating an offer price into an equity purchase price and an enterprise value, adding refinanced debt, transaction and financing fees, and minimum cash, then funding it with new debt, new equity, and cash on hand so that sources equal uses to the rupee.
3. Run a complete accretion/dilution analysis by hand for an all-stock, all-cash/debt, or mixed deal, computing the exchange ratio, pro-forma net income (net of after-tax financing cost), pro-forma share count, pro-forma EPS, and the accretion/dilution percentage. State the two "parity rules" that let you call the sign before you compute.
4. Separate accretion from value creation, quantify synergies with a present-value discipline (run-rate vs realized, phasing, cost-to-achieve, revenue vs cost), compute how much of the synergy value the acquirer pays away in the premium, and apply a skeptic's haircut that reflects the empirical record.
5. Analyze spin-offs, demergers, carve-outs and split-offs: explain the value-unlock logic, compute a sum-of-the-parts valuation and a when-issued "stub" value, work an entitlement ratio, and walk an Indian scheme of arrangement through NCLT under Sections 230–232 of the Companies Act, 2013.
6. Price a merger-arbitrage spread: gross spread, annualized return, market-implied completion probability, and a probability-weighted expected value against a defined break price. Explain why the arbitrageur's real product is a handicap on deal completion, not a view on value.
7. Read a fairness opinion with disciplined skepticism: name the banker conflicts (contingent/success fees, staple financing), the assumptions most often bent (terminal growth, discount rate, projections handed over by management), and the questions that turn a rubber-stamp into evidence.

Prerequisites & connections

Builds on. Phase 3 end-to-end: M3.01 (time value of money: every synergy PV and arb annualization is TVM), M3.03 (WACC and the cost of debt/equity you use to discount synergies and judge financing), M3.04–3.05 (DCF and owner earnings: what a target is worth before a premium), M3.06 (relative valuation/comps, whose EV/EBITDA multiples drive a sum-of-the-parts), M3.07 (capital allocation and the proxy, the record that tells you whether this management should be trusted to acquire), and M3.09 (the LBO: the financial buyer's model, and the leverage math a sources-and-uses table shares). From Phase 1: M1.07–M1.09 (goodwill, purchase accounting, and consolidation: what a deal does to the balance sheet). From Phase 2: M2.08 (quality of earnings: never model a target you have not QoE-cleared; a fabricated target is a fabricated synergy). From the Excel track: EX7.01 (professional modeling standards: the merger model is where the checks-and-flags row earns its keep). And the ethics/governance thread throughout, which peaks in M&A: a control transaction is the sharpest test of a board's fiduciary duty there is.

Feeds into. C5 (value a business three ways: the deal adds the control-premium and synergy layers), C7 (evaluate management and capital allocation: the M&A/buyback record is the highest-stakes evidence of allocation skill), C10 (the signature teardown: "is this company an acquirer, a target, or a break-up candidate?" belongs in every deep dive), and the sibling elective E11.01 (credit and covenants: the debt in your sources-and-uses lives or dies on the covenants E11.01 teaches you to read). E11.06 extends §4.5's spin-off work and §4.6's merger arbitrage into the rest of the event-driven set: rights offerings and the ex-rights price, the securities distributed in a deal that nobody wanted, the stub left standing after a recapitalisation, and the liquidation anchor.

The one-sentence version. A deal is a valuation with three extra moving parts bolted on: a control premium you pay for certain, synergies you hope to earn later, and a financing structure that decides who keeps the difference; the analyst's job is to keep those three honest while everyone in the room has an incentive to pretend the deal is better than it is.

Core teaching content

4.2 Sources & uses: the funding blueprint that must balance

Every deal model starts with one table that must balance to the rupee: where the money goes (uses) and where the money comes from (sources). Building it is the discipline that turns an offer price into a financeable transaction.

The uses side covers everything the buyer must pay for at close:

• Equity purchase price. Offer price per share × fully diluted target shares (include in-the-money options via the treasury-stock method). This is what the target's owners receive.
• Refinanced / repaid target debt. Most acquisition financings trigger change-of-control clauses, so the target's existing debt is typically refinanced at close. (Debt you assume and keep is not a cash use, but it is part of enterprise value.)
• Transaction fees. Advisory (M&A bankers), legal, accounting, proxy. Order of magnitude: ~1–2% of deal value, more on smaller deals.
• Financing fees. Underwriting/arrangement fees on the new debt and equity raised (often 1.5–3% of debt raised); these are capitalized and amortized, not expensed at close.
• Minimum cash. The cash the combined business must keep on the balance sheet to operate (you cannot sweep the target bone-dry).

The sources side covers everything that funds those uses:

• New debt. Term loans, bonds, bridge financing. Its size is constrained by the combined entity's leverage capacity (a Debt/EBITDA the lenders and covenants will bear, the E11.01 link).
• New equity. Shares issued to the market or to the target's holders (in a stock or mixed deal, the target's shareholders are themselves a "source," receiving stock instead of cash).
• Cash on hand. The acquirer's (and usable target) balance-sheet cash above the minimum.

The identity: total sources = total uses. In practice you fix the price (uses), decide the leverage the deal can carry and the equity you are willing to issue, and let cash on hand (or a residual new-equity/new-debt plug) balance the table. The moment sources and uses agree, you have a financeable structure and the two outputs the rest of the model needs: the pro-forma debt (for interest expense) and the pro-forma share count (for EPS). Worked example WE3 builds one end to end; the app's builder refuses to advance until your table balances, because a merger model that doesn't balance is not wrong at the margin — it is not a model.

A note on goodwill. Purchase accounting records the target's identifiable assets and liabilities at fair value; anything paid above that fair-value net-asset figure becomes goodwill on the combined balance sheet. Simplified, goodwill ≈ equity purchase price − target book (net-asset) value (a real deal first steps up tangible and intangible assets to fair value, which absorbs part of the gap). Goodwill is not amortized under Ind AS/IFRS or US GAAP; it is tested for impairment. A goodwill writedown, when it comes, is the accounting system finally admitting the acquirer overpaid (AOL–Time Warner, Kraft Heinz). You learned the mechanics in M1.07; here you learn to read the size of goodwill as a running tally of how much of the price rested on hope rather than on assets.

4.3 The accretion/dilution engine: done fully

Accretion/dilution answers one question: will this deal raise or lower the acquirer's earnings per share in the first full year? It is the first number every board and every sell-side analyst looks at, and it is pure arithmetic, which is exactly why you must understand both how to compute it and why, by itself, it means almost nothing about value (§4.4, Common Mistake #1).

The general recipe. Pro-forma EPS = pro-forma net income ÷ pro-forma shares, where:

• Pro-forma net income = acquirer net income + target net income − after-tax cost of the financing + after-tax synergies. The financing cost depends on how you paid:
• Cash from the balance sheet: subtract the after-tax foregone interest on the cash you spent (it was earning something).
• New debt: subtract the after-tax interest on the new debt = debt × pre-tax rate × (1 − tax).
• Stock: there is no financing charge in net income, but you issue shares, which hits the denominator.
• Pro-forma shares = acquirer shares + new shares issued to fund the deal. In an all-stock deal the new shares = target shares × the exchange ratio, where exchange ratio = offer price per target share ÷ acquirer share price. (Equivalently, new shares = equity purchase price ÷ acquirer share price.)

Accretion/dilution % = pro-forma EPS ÷ acquirer standalone EPS − 1. Positive is accretive; negative is dilutive.

The two parity rules: call the sign before you compute. These are the intuition that makes you fast and hard to fool:

1. All-stock deal: the deal is accretive if and only if the acquirer's P/E exceeds the target's P/E at the offer price (i.e., the P/E the acquirer is paying). Paying 20× with a currency the market values at 25× is buying earnings more cheaply than your own trade. That is mechanically accretive. If the multiples are equal, EPS is unchanged (P/E parity → neutral; see WE1 and P1). The deeper truth: this "accretion" is multiple arbitrage, not value creation. It works on paper the instant a high-multiple company buys a low-multiple one, synergies or none, which is precisely why accretion alone proves nothing.
2. All-cash/debt deal: the deal is accretive if and only if the target's earnings yield on the price paid (target net income ÷ equity purchase price, i.e., the inverse of the P/E paid) exceeds the after-tax cost of the cash or debt used. Funding a 5%-earnings-yield target with 6.75%-after-tax debt is dilutive by construction; funding a 10%-yield target with 7.5% debt is accretive (WE2, P2, P5). Cheap debt and a low purchase multiple are the two levers.

The cheap-currency trap and the breakeven synergy. Because a high-P/E acquirer can make almost any all-stock deal look accretive, "it's accretive" is the easiest sentence to say and the least informative. The honest companion number is the breakeven synergy: the after-tax synergy that makes a dilutive deal EPS-neutral (or, for an accretive deal, the synergy already implicit in the multiples). If a cash deal is 8.75% dilutive, ask "how much cost synergy would I need to close the gap?" and check whether that number is credible against the target's cost base (WE2). A deal that needs synergies equal to a fifth of the target's operating costs to break even on EPS is telling you the price is too high, whatever the strategic slides say.

Contribution vs consideration. A final cross-check, especially for mergers of near-equals: compare each side's contribution to combined earnings (or EBITDA, or cash flow) with the ownership each side receives. If the target contributes 25% of pro-forma earnings but its holders receive 38% of the combined shares (P10), the acquirer's owners have been diluted relative to what they brought, a red flag the raw accretion number can hide.

4.4 Synergies: the discipline and the skepticism

Synergies are the difference between a deal that is merely accretive and one that creates value. They are also the single most abused number in corporate finance. Your job is to hold both truths at once: synergies are real and sometimes large — and the base rate of acquirers achieving the synergies they promise is poor enough that the skeptic's prior should be "prove it."

The two kinds, and their very different credibility.

• Cost synergies. Eliminating duplicate overhead, plants, distribution, procurement scale, closing redundant functions. These are the credible kind: they are largely within management's control, quantifiable from the two cost bases, and delivered by decisions (close this facility, cut these roles) rather than by hoping customers behave. Most of the value in successful deals is cost synergy.
• Revenue synergies. Cross-selling, wider distribution, pricing power from a bigger footprint. These are the incredible kind: they depend on customers and competitors, arrive late if at all, and are the line item bankers inflate to justify a premium. A disciplined analyst discounts revenue synergies heavily, often to near zero, until a management team has earned the benefit of the doubt with a track record.

The present-value discipline (this is the whole game). A synergy is worth its present value, not its run-rate headline. To value it honestly you need four things the press release rarely gives cleanly:

1. Run-rate vs realized. The "$300m of synergies" figure is almost always the run-rate, the annual amount once fully implemented in year 3 or 4, not year 1. Model the phasing (e.g., 50% in year 1, 100% thereafter).
2. After-tax. Synergies are pre-tax operating improvements; convert to after-tax (× (1 − tax)) before discounting, because that is what reaches owners.
3. Cost to achieve. Synergies are not free: restructuring charges, severance, integration and IT spend, often a large one-time hit (sometimes 1–2× the annual run-rate) that you subtract, usually up front.
4. Discount rate. Discount the after-tax stream (a perpetuity, if the synergies are durable) at the combined firm's cost of capital.

Net synergy PV = PV(after-tax synergy stream, phased) − cost to achieve. WE4 and P7 do this end to end.

The value-transfer arithmetic: who actually keeps the synergies. Here is the number that separates analysts from cheerleaders. The acquirer pays the target's shareholders a premium for certain, today. It hopes to earn synergy PV over years, uncertain. The acquirer creates value only if net synergy PV exceeds the premium paid. Compute the share of synergies paid away = premium ÷ gross synergy PV. When that ratio approaches or exceeds 100%, the acquirer has handed the entire benefit of the deal to the seller and kept the risk. That is the "winner's curse" of M&A.

In WE4 the base case looks fine (premium = 79% of gross synergies, a thin positive), but a realistic haircut to 60% synergy realization turns a +$125m deal into a −$885m value destroyer. Great on the promised numbers, ruinous on the likely ones: that fragility is the signature of the average large acquisition, and it is why the empirical literature finds acquirers' shareholders, on average, do not gain from big deals while targets' shareholders capture most of the premium.

Dis-synergies and integration risk. The honest model also carries the minus signs: customer attrition (overlapping clients de-risk by dropping one supplier), culture clashes and talent flight, distraction of management from the base business, and the plain operational drag of integration. The best acquirers under-promise synergies and over-deliver; the worst do the reverse and take the writedown three years later.

Common mistakes & how experts think differently

1. Treating accretion as value creation. The commonest error in all of M&A analysis. A high-P/E company buying a low-P/E company is mechanically accretive with zero synergies and zero value created. It is multiple arbitrage, not economics. The expert computes accretion (the board will ask) but judges the deal on net synergy PV vs premium paid, and says out loud that an accretive deal can destroy value and a dilutive deal can create it.

2. Confusing equity value with enterprise value (and affected with unaffected price). Paying "$80 a share" is equity value; the business costs that plus the net debt you assume. Comparing an EV-based multiple to an equity-based one, or measuring the premium against the already-run-up price instead of the unaffected price, produces numbers that are simply wrong. The expert keeps a clean bridge from offer-per-share → equity value → enterprise value every single time.

3. Believing run-rate synergies as if they arrived on day one, tax-free and free of cost. The headline synergy is a year-3+ pre-tax figure with no cost-to-achieve. The expert phases it, taxes it, subtracts the (often large) integration cost, discounts it, and then compares the present value to the premium, and applies a skeptic's haircut, heaviest on revenue synergies.

4. Trusting revenue synergies at all without a track record. Cost synergies are decisions; revenue synergies are hopes about customers and competitors. The expert's default haircut on revenue synergies is severe, frequently to zero, reserved to be relaxed only for management teams that have delivered before.

5. Forgetting the winner's curse. In a competitive auction the winner is, by definition, the bidder most optimistic about the target, i.e., the one most likely to have overpaid. The expert treats "we won a hotly contested auction" as a risk flag, not a triumph, and checks how much of the synergy the premium already paid away.

6. Reading a fairness opinion as an endorsement. It is a narrow, conflicted, range-based letter written (usually) by the contingently-paid deal adviser. The expert ignores the letter, reads the underlying analyses in the proxy/scheme, and asks whose projections and which convenient assumptions produced the number.

7. Thinking a wide merger-arb spread is free money. The spread is the market's price for completion risk; a persistently wide spread means the market sees a real chance of a break (antitrust, financing, a wavering buyer). The expert treats the spread as information, estimates completion probability independently, prices the downside to the break price, and sizes for the loss, not the gain.

8. Ignoring the asymmetry in merger arb. Small, capped upside; large, uncapped-to-break-price downside. The expert never sizes an arb position as if the modest spread were the whole distribution; one broken deal at 10× the spread erases many closed ones.

9. Modeling the deal and skipping the quality of the target. A merger model built on a target with fabricated earnings (Phase 2) produces a precisely wrong synergy and accretion number. The expert QoE-clears the target before trusting a single line of its financials — garbage in, precise garbage out.

10. Treating spin-offs as merely "financial engineering." Sometimes it is; often it unlocks real value (focus, incentives, pure-play re-rating, optionability). The expert values the parts on their own multiples (SOTP), checks the stub, and, in India, reads the scheme for whether the swap ratio and structure quietly favor the promoter over minority holders.

11. Assuming the buyer's stock is a stable currency in a stock deal. In a fixed-exchange-ratio stock deal the value target holders receive floats with the acquirer's share price between signing and closing; a falling acquirer can turn a "fair" price unfair. The expert distinguishes fixed-ratio from fixed-value ("collar") structures and, as an arbitrageur, hedges the acquirer exposure.

12. Forgetting that the deal is a fiduciary and governance event, not just a spreadsheet. A control transaction is the sharpest test of whether a board serves shareholders or management/promoters (change-of-control payouts, conflicted advisers, related-party schemes). The expert runs the C7 governance lens over every deal with the same rigor as the accretion math: who benefits, and were the outside shareholders' interests represented?

Worked examples

Six workups, each with every number shown and independently verified. Two use Indian rupees (₹, in crore) and four use US dollars ($, in millions), per the both-markets rule. All companies are synthetic; real deals are named only as factual illustrations.

Worked example 1: All-stock deal, the P/E arbitrage, and why accretion ≠ value (US$)

Aurora Systems (synthetic) will acquire Belmont Cloud (synthetic) in an all-stock deal. Aurora: net income $600m, 300m shares, share price $50. Belmont: net income $180m, 90m shares, unaffected price $32; Aurora offers $40.00 per Belmont share (all stock). No synergies modeled — deliberately.

Step 1. The standalone multiples. Aurora EPS = 600 ÷ 300 = $2.00; Aurora P/E = 50 ÷ 2.00 = 25.0×. Belmont EPS = 180 ÷ 90 = $2.00; Belmont unaffected P/E = 32 ÷ 2.00 = 16.0×. The premium = 40 ÷ 32 − 1 = 25.0%; the P/E Aurora is paying = 40 ÷ 2.00 = 20.0×.

Step 2. Apply the parity rule before computing. Aurora's currency trades at 25×; it is paying 20× for Belmont's earnings. Acquirer P/E (25) > P/E paid (20) → the deal must be accretive, synergies or none. We now confirm the magnitude.

Step 3. The exchange ratio and new shares. Exchange ratio = offer ÷ acquirer price = 40 ÷ 50 = 0.80 Aurora shares per Belmont share. New Aurora shares issued = 90 × 0.80 = 72m. (Cross-check via equity value: offer equity = 90 × 40 = $3,600m; 3,600 ÷ 50 = 72m. ✓)

Step 4. Pro-forma EPS. Pro-forma net income = 600 + 180 = $780m (all-stock, so no financing charge). Pro-forma shares = 300 + 72 = 372m. Pro-forma EPS = 780 ÷ 372 = $2.0968.

Step 5. Accretion. 2.0968 ÷ 2.00 − 1 = +4.84% accretive.

Step 6. The lesson. Aurora just made itself 4.84% more profitable per share without creating a cent of value. It swapped 25×-valued paper for 20×-valued earnings. The target's unaffected equity was 90 × 32 = $2,880m; the offer values it at $3,600m; Aurora handed Belmont's holders a $720m premium for certain. Unless the combination produces synergy value exceeding $720m, the accretion is an accounting artifact and the premium is a wealth transfer to Belmont's shareholders. Accretion is the first number the board sees and the last number a good analyst trusts.

Worked example 2: Cash/debt deal, dilution, and the breakeven synergy (₹)

Bharat Consumer Ltd (synthetic) will acquire Konkan Foods (synthetic) for ₹6,000 crore, all cash, funded entirely by new debt at 9.0% pre-tax; tax rate 25%. Bharat: net income ₹1,200 crore, 100 crore shares, price ₹360. Konkan: net income ₹300 crore.

Step 1. Standalone and the parity rule. Bharat EPS = 1,200 ÷ 100 = ₹12.00; P/E = 360 ÷ 12 = 30.0×. After-tax cost of debt = 9.0% × (1 − 0.25) = 6.75%. Konkan's earnings yield on the price paid = 300 ÷ 6,000 = 5.0%. Parity rule: earnings yield (5.0%) < after-tax cost of debt (6.75%) → the deal must be dilutive. (Equivalently, Bharat is paying 6,000 ÷ 300 = 20.0× for earnings financed at an implied ~14.8× cost, which is 1/6.75%.)

Step 2. After-tax financing cost. New debt ₹6,000 crore × 6.75% = ₹405 crore of after-tax interest reduces combined earnings.

Step 3. Pro-forma EPS. Pro-forma net income = 1,200 + 300 − 405 = ₹1,095 crore. Shares are unchanged at 100 crore (all-cash/debt, no equity issued). Pro-forma EPS = 1,095 ÷ 100 = ₹10.95.

Step 4. Dilution. 10.95 ÷ 12.00 − 1 = −8.75% dilutive.

Step 5. The breakeven synergy. How much after-tax synergy makes this EPS-neutral (pro-forma NI back to ₹1,200 crore)? Required after-tax synergy = 1,200 − 1,095 = ₹105 crore; grossed up pre-tax = 105 ÷ (1 − 0.25) = ₹140 crore. So Bharat needs ₹140 crore of annual pre-tax synergies just to stop the deal from lowering its EPS, before it creates any value at all. Judge that against Konkan's cost base. If Konkan's total operating costs are, say, ₹1,700 crore, ₹140 crore is ~8% of them: plausible on cost synergies alone, but now the burden of proof is explicit and quantified, which is exactly where you want it.

Worked example 3: Sources & uses and the pro-forma share count, mixed consideration (US$)

Vertex Industrial (synthetic) acquires Cobalt Components (synthetic). Terms: offer $60.00 per Cobalt share for 40m shares (equity purchase price $2,400m), part cash / part stock. Vertex will refinance Cobalt's $600m of debt, pay $50m transaction fees and $30m financing fees, and fund $20m of minimum cash. Financing: $1,800m new debt; $900m of Vertex stock (Vertex price $45); $150m of Cobalt's own surplus cash; the rest from Vertex cash on hand. Vertex has 120m shares outstanding; Cobalt's book equity is $700m.

Step 1. Build the uses side.

Step 2. Build the sources side and solve for the plug.

The balancing cash on hand = 3,100 − 1,800 − 900 − 150 = $250m. Sources = uses = $3,100m. ✓

Step 3. Pro-forma share count. New Vertex shares issued = stock consideration ÷ Vertex price = 900 ÷ 45 = 20m. Pro-forma shares = 120 + 20 = 140m, the denominator for every EPS calculation the model will now run.

Step 4. Goodwill created. Simplified, goodwill ≈ equity purchase price − target book equity = 2,400 − 700 = $1,700m. (A full purchase-price allocation would first step up Cobalt's tangible and intangible assets to fair value, reducing residual goodwill; here we flag the simplification.) That $1,700m is the running tally of what Vertex paid above Cobalt's net assets: the number a future impairment test will judge.

Worked example 4: Synergy present value, and how the premium eats it (US$)

Vertex (from WE3, synthetic) claims the Cobalt deal delivers cost synergies. Target standalone equity value $5,000m; premium paid 40% → premium of $2,000m (offer equity $7,000m). Run-rate pre-tax cost synergies $300m/year; phased 50% in year 1, 100% from year 2 onward, perpetual. Tax 21%; discount rate 9%. One-time cost to achieve $400m, paid up front.

Step 1. After-tax run-rate synergy. 300 × (1 − 0.21) = $237m per year at full run-rate.

Step 2. Present-value the phased stream.

• Year 1 (50% realized): after-tax 0.5 × 237 = $118.5m; PV = 118.5 ÷ 1.09 = $108.72m.
• Year 2 onward (full $237m, perpetual): value as a perpetuity as of end of year 1 = 237 ÷ 0.09 = $2,633.33m; PV today = 2,633.33 ÷ 1.09 = $2,415.90m.
• Gross synergy PV = 108.72 + 2,415.90 = $2,524.62m.

Step 3. Net of cost to achieve. 2,524.62 − 400 = $2,124.62m net synergy PV.

Step 4. The value-transfer verdict. Net value to Vertex's shareholders = net synergy PV − premium paid = 2,124.62 − 2,000 = +$124.62m. Thin. The share of synergies paid away = premium ÷ gross synergy PV = 2,000 ÷ 2,524.62 = 79.2%. Vertex has handed nearly four-fifths of the deal's entire benefit to Cobalt's sellers and kept the integration risk.

Step 5. The skeptic's haircut (this is the point). The base case assumes 100% synergy realization. Apply the empirical prior, say only 60% of synergies actually land: gross synergy PV = 2,524.62 × 0.60 = $1,514.77m; net of cost to achieve = 1,514.77 − 400 = $1,114.77m; net value to Vertex = 1,114.77 − 2,000 = −$885.23m. The deal flips from a $125m gain to an $885m destruction of value on a wholly plausible shortfall. A transaction whose success requires perfect synergy delivery is not a good deal; it is a leveraged bet on flawless execution. That fragility, invisible in the accretion number, is the single most important thing to tell the board.

Worked example 5: Merger-arbitrage spread math on a cash deal (US$)

Meridian Devices (synthetic) has agreed to be acquired for $80.00 per share in cash. The stock trades at $77.50 today; expected time to close is 5 months. If the deal breaks, you estimate the stock falls to a standalone (break) price of $62.00.

Step 1. Gross spread and return-if-closed. Gross spread = 80.00 − 77.50 = $2.50. Gross spread % = 2.50 ÷ 77.50 = 3.23%.

Step 2. Annualize. Simple annualized = 3.23% × (12 ÷ 5) = 7.74%. (Compounded: 1.03226^(12/5) − 1 = 7.92%.) A 3.23% raw return is only worth chasing because it arrives in 5 months, not 5 years. Annualizing makes that explicit.

Step 3. The asymmetry. Downside if the deal breaks = 77.50 − 62.00 = $15.50 per share. Reward-to-risk = 2.50 ÷ 15.50 = 0.16: you risk $15.50 to make $2.50.

Step 4. Market-implied completion probability. Solve 77.50 = p × 80 + (1 − p) × 62: 77.50 = 62 + 18p → p = 15.5 ÷ 18 = 86.1%. The market prices an 86.1% chance of closing. This is your benchmark: only take the trade if your independent, research-driven estimate of completion is higher than 86.1%.

Step 5. Expected value at your own probability. Suppose your antitrust and financing work leaves you at p = 93%. Expected value = 0.93 × 80 + 0.07 × 62 = $78.74. Expected profit = 78.74 − 77.50 = $1.24 per share = 1.24 ÷ 77.50 = 1.60% over 5 months = 3.84% annualized. Positive, but modest, and a single broken deal costs you $15.50. The lesson: merger arb is a completion-handicapping business with capped upside and a truck-sized downside; the edge is in estimating p better than the market and sizing so that the breaks you will inevitably suffer do not sink the book.

Worked example 6: Spin-off, sum-of-the-parts and the value unlock (₹, Indian scheme of arrangement)

Sanchar Enterprises Ltd (synthetic) is a conglomerate with 120 crore shares trading at ₹150 (market cap ₹18,000 crore). It proposes to demerge its high-growth Digital arm from its slow-growth Infrastructure arm via a scheme of arrangement under Sections 230–232, NCLT-sanctioned, at an entitlement ratio of 1 DigitalCo share for every 1 Sanchar share held. Segment data: Infra EBITDA ₹1,500 crore, peer EV/EBITDA 6×, segment net debt ₹3,000 crore. Digital EBITDA ₹800 crore, peer EV/EBITDA 18×, no net debt.

Step 1. Value each part on its own multiple.

• Infra: EV = 1,500 × 6 = ₹9,000 crore; equity = 9,000 − 3,000 = ₹6,000 crore → per share 6,000 ÷ 120 = ₹50.
• Digital: EV = 800 × 18 = ₹14,400 crore; no net debt → equity = ₹14,400 crore → per share 14,400 ÷ 120 = ₹120 (entitlement 1:1, so DigitalCo will also have 120 crore shares).

Step 2. Sum of the parts. SOTP equity = 6,000 + 14,400 = ₹20,400 crore, or ₹170 per share.

Step 3. The unlock. Current market cap ₹18,000 crore (₹150/share) vs SOTP ₹20,400 crore (₹170/share) → a conglomerate discount of ₹2,400 crore, ~13.3%. The market is burying a business worth 18× EBITDA inside a group it values as if the whole thing deserved a blended low-teens multiple. Separating them lets Digital re-rate as a pure play, capturing that ₹20/share for shareholders who, post-record-date, will hold one Infra share (worth ~₹50) plus one DigitalCo share (worth ~₹120).

Step 4. The caveats a professional attaches. The ₹20,400 crore assumes (a) the peer multiples transfer cleanly to standalone entities, (b) central/holding costs and any unallocated debt are trivial (here assumed nil; in a real scheme, subtract them), and (c) the scheme's swap ratio and any promoter-favoring terms are fair to minority holders (read the scheme document and the registered-valuer report). The unlock is real often enough that spin-offs are a durable special-situations hunting ground, with GE's 2023–24 three-way split and Reliance's 2023 demerger of Jio Financial Services as the live-market illustrations. But the discount closes only if the separation is clean and the governance honest.

Practice set

Fourteen problems, ramped: guided (P1–P4, method prompted), independent (P5–P10, you choose the tool), timed (P11–P14, ~6 minutes each, exam conditions). All companies are synthetic. Work each fully before reading the solution; mix of ₹ and $.

P1 (guided: the P/E-parity case). Acquirer Delta Corp (synthetic): net income $400m, 100m shares, price $80. Target Echo Ltd (synthetic): net income $90m, 30m shares. Delta offers $60.00/share, all stock. (a) Delta's EPS and P/E. (b) The P/E Delta is paying for Echo. (c) The exchange ratio, new shares, pro-forma EPS, and accretion/dilution.

Solution. (a) EPS = 400 ÷ 100 = $4.00; P/E = 80 ÷ 4 = 20.0×. (b) Offer equity = 30 × 60 = $1,800m; P/E paid = 1,800 ÷ 90 = 20.0×. (c) Exchange ratio = 60 ÷ 80 = 0.75; new shares = 30 × 0.75 = 22.5m; pro-forma NI = 400 + 90 = $490m; pro-forma shares = 100 + 22.5 = 122.5m; pro-forma EPS = 490 ÷ 122.5 = $4.00; accretion = 4.00 ÷ 4.00 − 1 = 0.0%. Exactly neutral, because acquirer P/E (20) equals the P/E paid (20). This is the parity rule made concrete: an all-stock deal at your own multiple leaves EPS unchanged.

P2 (guided: cash deal, accretive). Acquirer Ganga Ltd (synthetic): net income ₹800 crore, 200 crore shares. Target Yamuna Foods (synthetic): net income ₹150 crore; offer ₹1,500 crore, all cash via debt at 10% pre-tax, tax 25%. (a) After-tax cost of debt and target earnings yield: call the sign. (b) Pro-forma EPS and accretion/dilution.

Solution. (a) After-tax cost of debt = 10% × 0.75 = 7.5%; target earnings yield = 150 ÷ 1,500 = 10.0%. Earnings yield (10%) > after-tax debt cost (7.5%) → accretive. (b) After-tax interest = 1,500 × 7.5% = ₹112.5 crore; pro-forma NI = 800 + 150 − 112.5 = ₹837.5 crore; shares unchanged 200 crore; pro-forma EPS = 837.5 ÷ 200 = ₹4.1875 vs standalone 800 ÷ 200 = ₹4.00; accretion = 4.1875 ÷ 4.00 − 1 = +4.69%. Cheap debt funding a higher-yield target is accretive, the mirror image of WE2.

P3 (guided: sources & uses). A deal has these uses (₹ crore): equity purchase price 3,600; refinance target debt 900; fees 120. Sources: new debt 2,500; target surplus cash 200; the balance from acquirer cash on hand. (a) Total uses. (b) Acquirer cash required.

Solution. (a) Total uses = 3,600 + 900 + 120 = ₹4,620 crore. (b) Acquirer cash = 4,620 − 2,500 − 200 = ₹1,920 crore. Sources (2,500 + 200 + 1,920 = 4,620) = uses. ✓ The plug is always the last, most flexible source, here the acquirer's own cash.

P4 (guided: merger-arb spread). Cash offer $52.00/share; target trades $50.40; expected close in 4 months; break price $41.00. (a) Gross spread and %. (b) Annualized return if it closes. (c) Market-implied completion probability.

Solution. (a) Gross spread = 52.00 − 50.40 = $1.60; % = 1.60 ÷ 50.40 = 3.17%. (b) Annualized = 3.17% × (12 ÷ 4) = 9.52%. (c) p = (50.40 − 41) ÷ (52 − 41) = 9.4 ÷ 11 = 85.5%. The market prices an 85.5% chance of closing; your job is to decide whether the true odds are better than that, and to note the downside is 50.40 − 41 = $9.40 against a $1.60 gain (reward/risk 0.17).

P5 (independent: breakeven synergy). Acquirer Sierra Ltd (synthetic): net income ₹2,000 crore, 400 crore shares. Target: net income ₹250 crore; offer ₹4,000 crore all cash via debt at 9% pre-tax, tax 25%. (a) Accretion/dilution with no synergies. (b) The pre-tax breakeven synergy.

Solution. (a) After-tax cost of debt = 9% × 0.75 = 6.75%; after-tax interest = 4,000 × 6.75% = ₹270 crore; pro-forma NI = 2,000 + 250 − 270 = ₹1,980 crore; EPS = 1,980 ÷ 400 = ₹4.95 vs 2,000 ÷ 400 = ₹5.00; dilution = 4.95 ÷ 5.00 − 1 = −1.0%. (b) Required after-tax synergy = 2,000 − 1,980 = ₹20 crore; pre-tax = 20 ÷ 0.75 = ₹26.67 crore. A small, easily achievable breakeven. This is a deal where the price is close to fair on EPS terms, and modest cost synergies tip it accretive.

P6 (independent: stock deal with synergies). Acquirer Ceres Inc (synthetic): price $50, net income $500m, 200m shares. Target: net income $120m; offer equity $1,800m, all stock. Expected pre-tax synergies $80m; tax 25%. (a) Offer P/E and the no-synergy sign. (b) Pro-forma EPS with synergies and the accretion.

Solution. (a) Offer P/E = 1,800 ÷ 120 = 15.0×; acquirer P/E = 50 ÷ (500/200) = 50 ÷ 2.50 = 20.0×. Acquirer 20× > 15× paid → accretive even before synergies. (b) New shares = 1,800 ÷ 50 = 36m; pro-forma shares = 200 + 36 = 236m; after-tax synergies = 80 × 0.75 = $60m; pro-forma NI = 500 + 120 + 60 = $680m; pro-forma EPS = 680 ÷ 236 = $2.8814 vs $2.50; accretion = 2.8814 ÷ 2.50 − 1 = +15.25%. Low purchase multiple plus real synergies compound into strong accretion — but remember (Mistake #1) to still test synergy PV vs the premium before calling it value-creative.

P7 (independent: synergy PV vs premium). Target standalone equity ₹8,000 crore; premium 35%. Run-rate pre-tax synergies ₹500 crore/year, perpetual from year 1 (no phasing), tax 25%, discount rate 10%; cost to achieve ₹400 crore up front. (a) Premium paid. (b) Net synergy PV. (c) Net value to the acquirer and the share of synergies paid away.

Solution. (a) Premium = 8,000 × 35% = ₹2,800 crore. (b) After-tax synergy = 500 × 0.75 = ₹375 crore; PV of perpetuity = 375 ÷ 0.10 = ₹3,750 crore; net of cost to achieve = 3,750 − 400 = ₹3,350 crore. (c) Net value to acquirer = 3,350 − 2,800 = +₹550 crore; share of synergies paid away = 2,800 ÷ 3,350 = 83.6%. The acquirer keeps only ~16% of the synergy value it hopes to create — and that is on full realization. Haircut the synergies to 70% and the ₹550 crore gain vanishes: a textbook thin-margin-of-safety deal.

P8 (independent: merger-arb expected value). Cash offer $30.00; target trades $28.80; break price $22.00; close in 6 months. Your estimate of completion is 90%. (a) Annualized return if it closes. (b) Break-even completion probability. (c) Expected value and expected return at your 90%.

Solution. (a) Gross % = (30 − 28.80) ÷ 28.80 = 4.17%; annualized = 4.17% × 2 = 8.33%. (b) p = (28.80 − 22) ÷ (30 − 22) = 6.8 ÷ 8 = 85.0%. (c) EV = 0.90 × 30 + 0.10 × 22 = $29.20; expected profit = 29.20 − 28.80 = $0.40; expected return = 0.40 ÷ 28.80 = 1.39% over 6 months (2.78% annualized). Your 90% exceeds the 85% break-even, so the trade has positive expected value, but it is thin (1.39%), and one break costs 28.80 − 22 = $6.80, seventeen times the expected profit. Size accordingly.

P9 (independent: sum-of-the-parts). ConglomCo (synthetic): market cap ₹30,000 crore, 150 crore shares. Segment A: EBITDA ₹2,000 crore, peer EV/EBITDA 7×, net debt ₹4,000 crore. Segment B: EBITDA ₹1,200 crore, peer EV/EBITDA 20×, no net debt. Central/holding net debt ₹2,000 crore. (a) Each segment's equity value. (b) SOTP equity and per share. (c) The unlock vs market.

Solution. (a) A: EV = 2,000 × 7 = ₹14,000 crore; equity = 14,000 − 4,000 = ₹10,000 crore. B: EV = 1,200 × 20 = ₹24,000 crore; equity = ₹24,000 crore. (b) SOTP equity = 10,000 + 24,000 − 2,000 (central debt) = ₹32,000 crore; per share = 32,000 ÷ 150 = ₹213.33. (c) Unlock = 32,000 − 30,000 = ₹2,000 crore = +6.7% vs the ₹30,000 crore market cap (₹200/share). A modest but real conglomerate discount, driven by Segment B's 20× multiple being diluted inside the group.

P10 (independent: merger of equals, ownership split). Company X (synthetic): price $60, 100m shares. Company Y (synthetic): price $40, 80m shares. All-stock merger; Y receives a 15% premium. (a) Offer per Y share and the exchange ratio. (b) New X shares and pro-forma count. (c) Y shareholders' ownership of the combined company.

Solution. (a) Offer per Y = 40 × 1.15 = $46.00; exchange ratio = 46 ÷ 60 = 0.7667. (b) New X shares = 80 × 0.7667 = 61.33m; pro-forma = 100 + 61.33 = 161.33m. (c) Y ownership = 61.33 ÷ 161.33 = 38.0%. Now the contribution cross-check (Mistake, §4.3): Y brought equity of 80 × 40 = $3,200m vs X's 100 × 60 = $6,000m. Y is ~34.8% of pre-premium combined equity but receives 38.0% of the company. The extra ~3 points is the premium, paid by X's shareholders in dilution.

P11 (timed: dilutive stock deal). Acquirer (synthetic): P/E 22×, EPS $2.00, net income $300m. Target (synthetic): net income $80m; offer equity $2,240m, all stock. (a) Acquirer price and shares. (b) The P/E paid: call the sign. (c) Pro-forma EPS and dilution.

Solution. (a) Price = 22 × 2 = $44; shares = 300 ÷ 2 = 150m. (b) P/E paid = 2,240 ÷ 80 = 28.0× > acquirer 22× → dilutive (high-multiple target bought with lower-multiple currency). (c) New shares = 2,240 ÷ 44 = 50.91m; pro-forma shares = 150 + 50.91 = 200.91m; pro-forma NI = 300 + 80 = $380m; EPS = 380 ÷ 200.91 = $1.8914; dilution = 1.8914 ÷ 2.00 − 1 = −5.43%. Paying up in multiple terms with your own cheaper stock dilutes — the reverse of WE1.

P12 (timed: arb annualized, day count). Cash offer $115.00; target trades $112.70; expected close in 73 days. Gross spread, % and annualized (365-day).

Solution. Gross spread = 115.00 − 112.70 = $2.30; % = 2.30 ÷ 112.70 = 2.04%; annualized = 2.04% × (365 ÷ 73) = 2.04% × 5 = 10.20%. A small 2.04% spread annualizes to a healthy 10.2% precisely because it closes in ~10 weeks, which is the whole point of annualizing.

P13 (timed: sources & uses, solve the equity plug). Uses ($m): equity purchase 5,000; refinance debt 1,200; fees 150. Sources: new debt 3,500; acquirer cash 600; target cash 250; the rest new equity issued. Find the new equity.

Solution. Total uses = 5,000 + 1,200 + 150 = $6,350m. New equity = 6,350 − 3,500 − 600 − 250 = $2,000m. Here the equity is the plug, the analyst's dial for how much dilution vs leverage the deal carries.

P14 (timed: spin-off entitlement and stub). Parent (synthetic) trades ₹450 pre-spin. The scheme grants 1 SpinCo share per 4 parent shares held (1:4). When-issued SpinCo trades ₹200. (a) SpinCo value attributable per parent share. (b) The implied RemainCo (stub) value per parent share.

Solution. (a) SpinCo per parent share = 200 × (1 ÷ 4) = ₹50. (b) Stub (RemainCo) = 450 − 50 = ₹400 per parent share. If your own valuation says RemainCo is worth ₹430, the market is under-pricing the stub by ₹30/share, a classic post-spin special-situations opportunity (the parts often trade inefficiently in the weeks around separation).

Applied mini-project: build a merger model and defend it

The task. Build a one-page (one-tab) merger model on a deal, using a real announced transaction if one is live and otherwise the synthetic prompt below, then write a one-page board memo delivering a recommendation. Budget ~3 hours. This is the compressed, by-hand version of what the app's CL-11.2 case grades in full.

Pick your deal.

• India (₹): a live or recent scheme/merger you can pull from BSE/NSE announcements and the scheme document (e.g., an all-stock bank or IT-services merger, or a demerger). Find the swap/entitlement ratio, the two companies' latest net income and share counts, and the fairness-opinion/valuer report.
• US ($): a live or recent announced acquisition from SEC EDGAR (the merger proxy, DEFM14A). Find the offer price, consideration mix, target and acquirer financials, and the fairness-opinion analyses.
• Synthetic fallback (use if no clean live deal): Orion Ltd (synthetic) acquires Lyra Systems (synthetic). Orion: net income ₹1,500 crore, 250 crore shares, price ₹300. Lyra: net income ₹280 crore, 70 crore shares, unaffected price ₹360. Orion offers ₹468/Lyra share (30% premium). Consideration: 60% stock (at Orion's ₹300), 40% cash funded by debt at 8.5% pre-tax; tax 25%. Management claims ₹250 crore run-rate pre-tax cost synergies (50% in year 1, full thereafter), ₹300 crore cost to achieve, discount rate 11%. Lyra carries ₹900 crore of debt to refinance; fees ₹150 crore.

Deliverables (the model must contain all six):

1. Sources & uses table that balances to the rupee/dollar, with the equity purchase price, refinanced debt, fees, and the funding split.
2. Pro-forma share count (acquirer shares + new shares issued for the stock portion).
3. Accretion/dilution, computed with and without synergies, showing after-tax financing cost and after-tax synergies as separate lines, plus the breakeven synergy if dilutive.
4. Synergy PV vs premium: net synergy PV (phased, after-tax, less cost to achieve), the premium paid, the net value to the acquirer, and the share of synergies paid away, with a 60%-realization haircut scenario.
5. A merger-arb line (if the target is public and the deal announced): gross spread, annualized return, and market-implied completion probability.
6. A one-page board memo (Minto-style, conclusion first): recommend proceed / renegotiate / walk, with the two numbers that decide it and the one governance question (who benefits; were minority holders represented; is the fairness opinion conflicted?).

Scoring rubric (0–2 each; ≥10/14 with no zero is a pass):

Case Lab: run case CL-11.2 in the app's Cases tab for this module.

Reading & resources

• Rosenbaum & Pearl, Investment Banking: Valuation, LBOs, M&A, and IPOs. The industry-standard manual for these mechanics: sources & uses, accretion/dilution, and the merger model built line by line. Read the M&A and merger-consequences chapters beside your own model. [Paid] [Intermediate]
• Aswath Damodaran, "Acquisitions and Takeovers" chapter and his M&A lecture notes/spreadsheets (pages.stern.nyu.edu/~adamodar). The clearest free treatment of why most acquisitions fail to create value, the synergy-valuation discipline, and the control premium, with downloadable models. [Free] [Intermediate]
• SEC EDGAR, a live merger proxy (DEFM14A) for any recent US deal: read the "Background of the Merger," the "Opinion of the Financial Advisor," and the projections. The fairness opinion in its native habitat. Read three and the pattern (management projections, contingent fees, a range whose midpoint hugs the price) becomes obvious. [Free] [Advanced]
• BSE/NSE scheme filings and the SEBI (LODR) scheme framework + SEBI (SAST) Takeover Regulations, 2011. The Indian route to control and separation: read one real scheme of arrangement (find the swap ratio, appointed date, record date) and the takeover-code open-offer mechanics. [Free] [Advanced]
• Bruner, Applied Mergers and Acquisitions (or the shorter Deals from Hell). The definitive scholarly-yet-practical treatment, and the case studies of value destruction that teach synergy skepticism better than any formula. [Paid] [Advanced]
• Joel Greenblatt, You Can Be a Stock Market Genius. The classic on spin-offs, stubs, and special situations from an investor who made a career of them: the intuition behind §4.5 and §4.6. [Paid] [Beginner–Intermediate]
• Kraft Heinz FY2018 results and the ~$15.4bn impairment; the AOL–Time Warner ~$99bn 2002 goodwill writedown (public filings/coverage). Read the goodwill-impairment disclosures as the accounting system's confession of overpayment — the end of the story whose beginning is a synergy slide. [Free] [Intermediate]
• A live merger-arbitrage spread you track for four weeks. Pick one announced cash deal, record the spread, annualized return, and implied probability weekly, and read every regulatory update. Nothing teaches completion-handicapping like watching a real spread move on real news (Microsoft–Activision was a two-year masterclass; find the current equivalent). [Free] [Intermediate]

The Modern Analyst's Addendum

Everything above teaches this skill from first principles, by hand — that is how you learn it, and the mastery check still tests it that way. This addendum shows how a working analyst amplifies the same skill today. It adds; it never replaces. (R1/R10)

AI-Augment this skill

{
  "skill": "The full merger-model and merger-arb toolkit: sources & uses, accretion/dilution and its two parity rules, the synergy present-value discipline and the value-transfer test, sum-of-the-parts and stub valuation for spin-offs, and pricing a merger-arb spread into a market-implied completion probability",
  "use": "This module's real AI use is clerical extraction from a deal document, not the judgment calls. (1) Pull the deal terms out of a merger proxy (US DEFM14A), an Indian scheme of arrangement, or an exchange announcement — offer price, consideration mix, financing condition, termination/break fee, outside date, and the regulatory approvals required — into a table you check line by line against the filing's own clause references, the same discipline §4.7 already applies to a fairness opinion. (2) Draft the mechanical skeleton of a sources-and-uses table or an accretion/dilution schedule from numbers you supply, so the structure exists in seconds and every cell is still one you populated and can defend. (3) Summarize a proxy's 'Background of the Merger' into a dated sequence of events you then verify against the filing itself. Never ask it to judge completion probability, call accretion vs value creation, or size a synergy haircut — those are this module's own arithmetic and its own skepticism, and outsourcing either defeats the point.",
  "tools": ["Chat assistants (Claude, ChatGPT) with the filing text pasted or uploaded, for deal-term and timeline extraction", "SEC EDGAR full-text search, for the source DEFM14A or 8-K itself", "NSE/BSE corporate-announcements pages and scheme documents, for the Indian filings", "a spreadsheet or your Python notebook, for the sources-and-uses or arb tracker the extraction feeds"],
  "prompt": "From this [merger proxy / scheme of arrangement / exchange announcement] excerpt, extract into a table, one row per field: offer price and form of consideration; financing condition (yes/no) and financing source; termination/break fee (amount, which party pays it, and its trigger); the outside date; and every regulatory approval required, with its statutory deadline if the filing states one. Quote the exact clause for each field. Write NOT STATED rather than inferring anything.",
  "verify": "Open the actual clause the tool quoted for the break fee and the financing condition and confirm both yourself — a wrong break fee or a missed financing condition changes your read of completion risk, which is the one input in this module's spread math that is genuinely a judgment call, not an extraction. And per the Quantitative lens below, your completion-probability estimate is far more sensitive to tomorrow's closing print than to a few dollars of error in your own break-price assumption — re-price the spread against the CURRENT quote before trusting an extraction that is even a day old.",
  "diy": "The mastery check hands you a spread — an offer price, a current price, a timeline — with no filing behind it, and asks you to build the sources & uses, call accretion or dilution before computing it, value the synergies with the present-value discipline, and invert the spread to a probability by hand. No extraction tool sits in that room; the numbers it can fetch are not the skill being tested."
}

Modern Data Analysis

By hand first. WE5 solved one static snapshot: a single offer, a single current price, a single assumed break price in; one probability, one expected value, one annualized return out. That is correct, and it is frozen the moment you close the spreadsheet: the current price will print again tomorrow, and the break-price assumption was always a judgment, not a fact.

Today's workflow. Turn the spread math into a function of its three inputs instead of a one-time calculation, and two things become possible that hand arithmetic makes tedious: sweeping the break-price assumption across a plausible range instead of committing to a single number, and asking, for a given deal, which of the two uncertain inputs (the break price you estimated, or the market price that will move regardless of your estimate) actually moves the answer more. The Quantitative lens below runs that comparison on WE5's own numbers and the result is not the intuitive one. The same function re-prices the position every time the stock reprints, which is what the "track a live spread for four weeks" resource above is really asking you to operationalize rather than re-key by hand each week.

Tools & sources (IN + US). numpy/pandas for the sensitivity sweep and a running tracker keyed by date; no vendor feed is required for the arithmetic itself, only for its inputs. US. SEC EDGAR full-text search for the source DEFM14A and any deal-term-amending 8-K; FRED's DGS3MO (3-month Treasury) as the riskless benchmark an annualized arb return should be measured against, not admired in isolation (a 3.84% annualized arb return means little until you know what a T-bill was paying that month). India. NSE/BSE corporate-announcements pages for the public announcement and detailed public statement on an open offer; the CCI's own combination-order register (cci.gov.in) for the actual approval-date track record on past deals, which is a better guide to a live deal's likely timeline than the statutory ceiling alone; FBIL for the short-tenor INR benchmark equivalent to DGS3MO.

# Merger-arb spread inversion + sensitivity — R3, in-session
def implied_p(offer, current, break_px):
    return (current - break_px) / (offer - break_px)

def dp_dbreak(offer, current, break_px):
    return (current - offer) / (offer - break_px) ** 2

def dp_dcurrent(offer, break_px):
    return 1.0 / (offer - break_px)

# WE5: Meridian Devices — offer $80.00, current $77.50, assumed break $62.00
offer, current, break_px = 80.00, 77.50, 62.00
print(f"implied p = {implied_p(offer, current, break_px):.4%}")   # WE5 states 86.1%

# sweep the break-price ASSUMPTION — how much of the answer is really an assumption?
for b in (50, 57, 62, 67, 70):
    print(f"break={b:5.2f}  implied p={implied_p(offer, current, b):.4%}")

# local sensitivity: probability-points moved per $1 — the assumption vs. the quoted price
print("dp/d(break)  :", dp_dbreak(offer, current, break_px))
print("dp/d(current):", dp_dcurrent(offer, break_px))

Verify. This reproduces WE5's own figures exactly: implied probability 86.11%, expected value at your own p=93% of $78.74, expected profit $1.24, and 3.84% annualized, the anchor for everything below.

Quantitative lens

The spread-to-probability inversion is exact given the break price; the honest modern exercise is asking how much the answer depends on that one assumed number. WE5 fixes the break price at $62.00 and reads off p = 86.1%. Sweep the assumption instead of committing to it: at break=$57 (a smaller assumed fall) p rises to 89.1%; at break=$67 (a larger assumed fall) p drops to 80.8%. That is an 8.4-percentage-point band from a ±$5 uncertainty band on a number nobody observes directly. The closed form is dp/d(break) = (current − offer) / (offer − break)², which evaluates to −0.77 percentage points of implied probability per $1 of break-price error at WE5's numbers.

That sensitivity is smaller than the one nobody worries about. Hold the break-price assumption fixed and move only the quoted current price. That number requires no judgment at all, just a stock ticker, and dp/d(current) = 1 / (offer − break) evaluates to +5.56 percentage points per $1. That is 7.2× larger than the break-price sensitivity, and the ratio between them is not a coincidence of these particular numbers: algebraically, dp/d(break) ÷ dp/d(current) = −(gross spread) / (offer − break), here −2.50 / 18.00 ≈ −13.9%, matching the 1-in-7.2 ratio exactly. The tighter the spread relative to the offer-to-break range (the more "sure thing" the market thinks a deal is), the less the implied probability depends on your own break-price judgment, and the more it depends on a print you don't control. An arbitrageur who spends a research budget refining the break-price estimate while ignoring how a routine overnight move re-prices the position has the ratio backwards.

A textbook base rate for "how often do announced deals break" does not exist. It is a fact about which multi-decade sample you pick, and the two most-cited academic studies bracket a wide range. Malcolm Baker and Serkan Savasoglu ("Limited Arbitrage in Mergers and Acquisitions," Journal of Financial Economics 64, 2002) studied 1,901 US merger offers from 1981–1996 and found a 22.7% break rate (and, counting competing offers, the target remained independent a year later in 16.3% of cases, a stricter bar than simple completion). Gaurav Jetley and Xinyu Ji ("The Shrinking Merger Arbitrage Spread," Financial Analysts Journal, 2010) studied 2,182 US deals from 1990–2007 and found the completion rate stable, since 1993, in the mid-80s-to-mid-90s-percent range: a break rate of roughly 4%–15%. Two respected, similarly-sized studies of the same country's deal market, on overlapping-but-different multi-decade windows, bracket a break rate that differs by up to 5.7× (22.7% ÷ 4%). Mitchell & Pulvino ("Characteristics of Risk and Return in Risk Arbitrage," Journal of Finance, 2001; 4,750 deals, 1963–1998) add the shape, not just the rate: risk-arbitrage returns correlate with the broad market in sharp downturns, when deals are likelier to break, but show little correlation in flat or rising markets, the same asymmetric profile G1/DV1.02 teaches as a written put's payoff.

Honest limits. The whole inversion above assumes a two-outcome world: the deal closes at the offer price, or it breaks to a single assumed break price. Real deals do neither cleanly often enough to matter. A competing bid can raise the offer, a renegotiation can lower it, and Baker & Savasoglu's own 16.3% "remained independent" figure (against their 22.7% simple break rate) shows the two-outcome frame already undercounts the ways a deal can fail to close exactly as announced. The break price itself is a valuation judgment, what the standalone company would be worth absent the bid, not a market-observable fact, and nothing here supplies that judgment; the sensitivity table converts "I am not sure of the break price" into "here is exactly what that uncertainty is worth," which is honest, not solved. The two academic base rates are decades old, US-only, and, despite a search, I found no comparably-sized published study of Indian open-offer or scheme completion rates to cite.

So an Indian deal should be priced off the regulatory clock, not an imported US base rate: the Competition (Amendment) Act, 2023 cut the CCI's overall combination-review timeline from 210 to 150 days, with a 30-calendar-day deemed-approval window for the prima facie opinion if the CCI is silent; a SEBI open offer runs roughly 60–75 calendar days end to end once the detailed public statement is filed. Those figures bound how long a spread must annualize over. They are not a probability that it survives that long.

Do it in code: turn the spread inversion into a function of its three inputs, sweep the break-price assumption instead of committing to one number, and compare that sensitivity against the sensitivity to the quoted price before deciding where your research time is actually worth spending. See G1/QM1.01, G1/DV1.02 and G2/QD1.01.

Where this goes next: galaxy cross-links

• G3 · CN6.01 Deal Rationale, Synergies & Their Traps: the diligence seat that stress-tests a synergy case before the merger model in this module gets built; CN6.01 names this module as the sibling that owns the mechanics it hands off to.
• G3 · CN6.02 Portfolio Strategy, Build-Buy-Partner, PMI & Divestitures: picks up once accretion/dilution has been computed and the deal actually closes: Day-1 readiness, the hundred-day plan, and the mirror-image discipline of a clean divestiture.
• G1 · QM1.01 Probability, Distributions & Estimation: the estimation discipline behind turning "likely" into the defensible number this addendum's spread inversion depends on.
• G1 · DV1.02 Options: Parity, Binomial Trees, Black-Scholes-Merton & the Greeks: the replicating-portfolio logic that gives a merger-arb position its precise payoff shape: capped upside, a fat left tail to the break price, empirically confirmed to behave like a written put.
• G2 · QD1.01 Market & Fundamental Data Pipelines + Vendor Landscape: the point-in-time discipline (corporate actions, dated filings, no survivorship) the "track a live spread for four weeks" resource needs the moment you automate it across more than one deal.

Teach it back & journal

Feynman prompt. Write a one-page explainer for a smart friend who knows nothing about finance, titled "Why 'the deal makes our earnings go up' is a trick — and what actually matters." You must use, in plain words: (1) how a company with expensive stock can buy a company with cheap stock and automatically look more profitable per share without creating anything (the P/E-arbitrage idea from WE1); (2) the one comparison that tells you whether a deal really created value (net synergy PV vs the premium paid); and (3) why "we'll cross-sell to each other's customers" deserves far less trust than "we'll close the duplicate head office." No formulas. If you cannot explain accretion-without-value to a non-finance friend, you do not yet own it.

Journal reflection. Open your decision journal and write a deal-skeptic's ledger entry: (1) pick one large acquisition you can find (from the news or your own watchlist) and, before reading any post-mortem, write down whether you'd have expected it to create or destroy value and why, then note what actually happened; (2) name the one synergy claim in that deal you would have haircut hardest, and to what; (3) if it was a public deal, what did the merger-arb spread do over its life, and what did that spread know that the equity story didn't; and (4) one sentence you commit to writing in every future deal memo. A candidate: "This deal is accretive/dilutive by X%, but it creates value only if net synergy PV exceeds the ₹Y premium, which requires Z% synergy realization — and here is why I do or don't believe that." Date it; the M8 teardown will ask you to reread this before you ever call a company "a likely acquirer" or "a break-up candidate."

This module's flashcards and mastery quiz are wired into the app: see the node's Quiz and Reviews.